References
- Weiss KB, Gap PJ, Wapner DK. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and morality. Annu Rev Public Health 1993; 14: 491–513
- National Asthma Education Program &pert Pand. Guidelines for the diagnosis and management of asthma. Bethesda: US Dept of Health and Human Services, 1991 Aug; NIH publication No. 91–3042
- Kalliel JN, Goldstein BM, Braman SS, et al. High frequency of atopic asthma in a pulmonary clinic population. Chest 1989; 96(6): 1336–40
- Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Eng! J Med 1989; 320(5): 271–7
- Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332(3): 133–8
- Lemanske RF Jr. Inflammation's role in mild and moderate asthma. J Respir Dis 1992; 13(10): S9–14
- Reed CE. Pathogenesis of asthma. Airway Diseases 1985 Dec; 10–6
- Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139(3): 806–17
- Roche WR, Beasley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1(8637): 520–4
- Bukantz SC. Acute severe asthma: the late-phase reaction and the continuing challenge. (Editorial) Hosp Pract (Off Ed) 1986; 21 (11): 10–6
- Sean MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336(8728): 1391–6
- Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326(8): 501–6
- McFadden ER Jr. The beta2-agonist controversy revisited. Ann Allergy Asthma Immunol 1995; 75(2): 173–6
- Mullen M, Mullen B, Carey M. The association between beta-agonist use and death from asthma: a meta-analytic integration of case-control studies. JAMA 1993; 270(15): 1842–5
- Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342(8875): 833–7
- Cockcroft DW. Beta-agonists, airway hyperresponsiveness, and asthma. (Editorial) J Allergy Clin Immunol 1992; 90(5): 739–41
- D'Alonzo GE, Nathan RA, Henochowicz: S, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271(18): 1412–6
- Toogood JH. What are the clinically relevant risks, and what ro do? Making better—and safer—use of inhaled steroids. J Respir Dis 1993; 14(2): 221–7
- Reed CE. Aerosol glucocorticoid treatment of asthma: adults. Am Rev Respir Dis 1990; 141(2 Pt 2): S82–8
- Larsen JS, Hahn M, Kochevar JW, et al. Administration errors with a conventional metered dose inhaler versus a novel breath actuated device. Ann Allergy 1993; 71(2): 103–6
- The role of the allergist in cost-effective treatment of asthma. Arlington Heights, Ill: American College of Allergy, Asthma & Immunology, 1995 May: 1–11